In Silico Analysis of Inhibiting Papain-like Protease from SARS-CoV-2 by Using Plant-Derived Peptides

被引:0
作者
Mohammad Moradi
Reza Golmohammadi
Ali Najafi
Mehrdad Moosazadeh Moghaddam
Mahdi Fasihi-Ramandi
Reza Mirnejad
机构
[1] Systems Biology and Poisonings Institute,Molecular Biology Research Center
[2] Baqiyatallah University of Medical Sciences,Department of Biotechnology, Faculty of Biological Science and Technology
[3] University of Isfahan,Applied Biotechnology Research Center
[4] Baqiyatallah University of Medical Sciences,undefined
来源
International Journal of Peptide Research and Therapeutics | 2022年 / 28卷
关键词
Plant-derived peptides; In silico; SARS-CoV-2; Papain-like protease;
D O I
暂无
中图分类号
学科分类号
摘要
SARS-CoV-2 is a corona virus that has been the cause for one of the deadliest pandemics of history, started since 2019. Suppressing the activity of the critical enzymes in the SARS-CoV-2 could potentially inhibit a vital step in viral life cycle. Papain-like protease (PLpro) could be regarded as a critical enzyme in viral replication of SARS-CoV-2. In this research, it was aimed to suppress the activity of PLpro enzyme by using potential plant-derived protease inhibitor peptides. For this purpose, 11 plant derived peptides that could potentially inhibit protease activity were selected from literature. The structures of the PLpro and the peptide ligands were acquired from PDB (protein data bank) and after structural optimization, were docked by using HADDOCK 2.4 program. Analyzing the results indicated that VcTI from Veronica hederifolia provides effective molecular interactions at both liable Zn site and classic active site of PLpro, making it a potential inhibitory ligand for this enzyme that could be used for halting the replication of SARS-CoV-2. Molecular dynamic assay confirmed that the selected receptor and ligand complex was stable. Future in vitro and in vivo investigations are required to verify the efficiency of this compound as a potential therapeutic against SARS-CoV-2 infection.
引用
收藏
相关论文
共 236 条
[1]  
Ahmadi K(2021)Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study J Biomol Struct Dyn 29 21-38
[2]  
Farasat A(2021)Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors Bioorg Med Chem 115 31391-31400
[3]  
Rostamian M(2015)The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds Antivir Res 278 341-347
[4]  
Johari B(2003)Unbound form of tomato inhibitor-II reveals interdomain flexibility and conformational variability in the reactive site loops J Biol Chem 12 1-12
[5]  
Madanchi H(2011)Plant protein proteinase inhibitors: structure and mechanism of inhibition Curr Protein Pept Sci 10 15277-15288
[6]  
Amin SA(2021)In silico design of quadruplex aptamers against the spike protein of SARS-CoV-2 Inform Med Unlocked 37 2669-2677
[7]  
Banerjee S(2020)Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2 Sci Rep 37 5201-5211
[8]  
Ghosh K(1998)Structural determinants of the bifunctional corn Hageman factor inhibitor: X-ray crystal structure at 1.95 Å resolution Biochemistry 34 27760-27768
[9]  
Gayen S(2019)Structural insights into the unique inhibitory mechanism of Kunitz type trypsin inhibitor from J Biomol Struct Dyn 282 12916-12924
[10]  
Jha T(1995) L. Biochemistry 11 2341-245